Literature DB >> 31268779

Alcohol-induced adipose tissue macrophage phenotypic switching is independent of myeloid Toll-like receptor 4 expression.

Melissa A Fulham1,2, Anuradha Ratna2, Rachel M Gerstein3,4, Evelyn A Kurt-Jones3,5, Pranoti Mandrekar1,2,3.   

Abstract

Alcoholic liver disease results from a combination of immune and metabolic pathogenic events. In addition to liver injury, chronic alcohol consumption also causes adipose tissue inflammation. The specific immune mechanisms that drive this process are unknown. Here, we sought to determine the role of the innate immune receptor Toll-like receptor 4 (TLR4) in alcohol-induced adipose tissue inflammation. Using a model of chronic, multiple-binge alcohol exposure, we showed that alcohol-mediated accumulation of proinflammatory adipose tissue macrophages was absent in global TLR4 knockout mice. Proinflammatory macrophage accumulation did not depend on macrophage TLR4 expression; LysMCre-driven deletion of Tlr4 from myeloid cells did not affect circulating endotoxin or the accumulation of M1 macrophages in adipose tissue following alcohol exposure. Proinflammatory cytokine/chemokine production in the adipose stromal vascular fraction also occurred independently of TLR4. Finally, the levels of other adipose immune cells, such as dendritic cells, neutrophils, B cells, and T cells, were modulated by chronic, multiple-binge alcohol and the presence of TLR4. Together, these data indicate that TLR4 expression on cells, other than myeloid cells, is important for the alcohol-induced increase in proinflammatory adipose tissue macrophages.

Entities:  

Keywords:  TLR4; adipose; alcohol; inflammation

Mesh:

Substances:

Year:  2019        PMID: 31268779      PMCID: PMC6850994          DOI: 10.1152/ajpcell.00276.2017

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  68 in total

1.  B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies.

Authors:  Daniel A Winer; Shawn Winer; Lei Shen; Persis P Wadia; Jason Yantha; Geoffrey Paltser; Hubert Tsui; Ping Wu; Matthew G Davidson; Michael N Alonso; Hwei X Leong; Alec Glassford; Maria Caimol; Justin A Kenkel; Thomas F Tedder; Tracey McLaughlin; David B Miklos; H-Michael Dosch; Edgar G Engleman
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

Review 2.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

3.  Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.

Authors:  Sayaka Inokuchi; Hidekazu Tsukamoto; EekJoong Park; Zhang-Xu Liu; David A Brenner; Ekihiro Seki
Journal:  Alcohol Clin Exp Res       Date:  2011-04-04       Impact factor: 3.455

4.  The NLRP12 inflammasome recognizes Yersinia pestis.

Authors:  Gregory I Vladimer; Dan Weng; Sara W Montminy Paquette; Sivapriya Kailasan Vanaja; Vijay A K Rathinam; Marie Hjelmseth Aune; Joseph E Conlon; Joseph J Burbage; Megan K Proulx; Qin Liu; George Reed; Joan C Mecsas; Yoichiro Iwakura; John Bertin; Jon D Goguen; Katherine A Fitzgerald; Egil Lien
Journal:  Immunity       Date:  2012-07-27       Impact factor: 31.745

5.  Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

Authors:  Jeremy E Davis; Nicholas K Gabler; Jennifer Walker-Daniels; Michael E Spurlock
Journal:  Obesity (Silver Spring)       Date:  2008-04-10       Impact factor: 5.002

6.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.

Authors:  Markus Feuerer; Laura Herrero; Daniela Cipolletta; Afia Naaz; Jamie Wong; Ali Nayer; Jongsoon Lee; Allison B Goldfine; Christophe Benoist; Steven Shoelson; Diane Mathis
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

7.  An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice.

Authors:  Sanjoy Roychowdhury; Megan R McMullen; Michele T Pritchard; Amy G Hise; Nico van Rooijen; M Edward Medof; Abram B Stavitsky; Laura E Nagy
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

8.  A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.

Authors:  Shannon M Reilly; Maryam Ahmadian; Brian F Zamarron; Louise Chang; Maeran Uhm; BreAnne Poirier; Xiaoling Peng; Danielle M Krause; Evgenia Korytnaya; Adam Neidert; Christopher Liddle; Ruth T Yu; Carey N Lumeng; Elif A Oral; Michael Downes; Ronald M Evans; Alan R Saltiel
Journal:  Nat Commun       Date:  2015-01-12       Impact factor: 14.919

9.  Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice.

Authors:  David L Morris; Kae Won Cho; Jennifer L Delproposto; Kelsie E Oatmen; Lynn M Geletka; Gabriel Martinez-Santibanez; Kanakadurga Singer; Carey N Lumeng
Journal:  Diabetes       Date:  2013-03-14       Impact factor: 9.461

10.  Sexual Dimorphism in Alcohol Induced Adipose Inflammation Relates to Liver Injury.

Authors:  Melissa A Fulham; Pranoti Mandrekar
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

View more
  3 in total

Review 1.  Alcoholic liver disease: a new insight into the pathogenesis of liver disease.

Authors:  Seol Hee Park; Young-Sun Lee; Jaemin Sim; Seonkyung Seo; Wonhyo Seo
Journal:  Arch Pharm Res       Date:  2022-06-27       Impact factor: 6.010

Review 2.  Immunological mechanisms and therapeutic targets of fatty liver diseases.

Authors:  Hua Wang; Wajahat Mehal; Laura E Nagy; Yaron Rotman
Journal:  Cell Mol Immunol       Date:  2020-12-02       Impact factor: 11.530

3.  Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease.

Authors:  Anuradha Ratna; Arlene Lim; Zihai Li; Josepmaria Argemi; Ramon Bataller; Gabriela Chiosis; Pranoti Mandrekar
Journal:  Hepatol Commun       Date:  2021-05-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.